Hyperpolarized Diethyl Ether for Sub-second Pulmonary MRI
用于亚秒级肺部 MRI 的超极化乙醚
基本信息
- 批准号:10221779
- 负责人:
- 金额:$ 22.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-22 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAffectAirAlveolarAnestheticsAnimalsAsthmaBronchiolitisCenters for Disease Control and Prevention (U.S.)Cessation of lifeChronic Obstructive Airway DiseaseClinicalClinical TrialsClinical/RadiologicComplexComputer softwareContrast MediaCustomDevicesDiagnosisDiffusionDiseaseDisease OutbreaksDoseEarly DiagnosisEffectivenessElectronic cigaretteEquipmentEthyl EtherFDA approvedFaceFutureGasesGoalsHourHumanHuman ResourcesHydrocarbonsHydrogenationImageImaging TechniquesInfrastructureInhalationInvestmentsIonizing radiationLiquid substanceLungLung diseasesMRI ScansMagnetic Resonance ImagingMammary UltrasonographyMedicineMonitorNoble GasesNoiseNuclearOutcomePartial PressurePathologyPatientsPerfusionPhasePhase I Clinical TrialsPhysiologicalPneumoniaPopulationPositron-Emission TomographyProcessProductionPropanePropertyProtonsPulmonary FibrosisPulmonologyReactionRecording of previous eventsRelaxationReportingResearchResolutionRoentgen RaysSafetyScanningSignal TransductionSpeedStructureTechnologyTemperatureThree-Dimensional ImagingTissuesWorkX-Ray Computed Tomographycancer imagingcatalystclinical imagingclinical translationconstrictioncostdensityhigh throughput technologyimaging modalityimaging studyin vivolung imaginglung injurymagnetic fieldnew technologynon-invasive imagingnovelprocess optimizationprogramspulmonary functionscreeningsuccesstechnology developmenttreatment responsetumorvapingventilationvinyl ether
项目摘要
PROJECT SUMMARY (30-line limit)
Deadly diseases such as chronic obstructive pulmonary disease (COPD), asthma, lung injury, constrictive
bronchiolitis, and pulmonary fibrosis affect >300 million people worldwide and cause ~3 million annual deaths.
However, there is currently no widespread clinical imaging modality to perform high-resolution functional lung
imaging: Computed Tomography (CT), conventional MRI, and X-ray can only provide structural images of dense
tissues—informing about pathologies like tumors and pneumonia—but yielding little or no information about lung
ventilation, perfusion, alveoli size, gas-exchange efficiency, etc. This state of affairs contrasts with cancer
imaging, which includes MRI, CT, ultrasound, mammography, Positron Emission Tomography (PET) and others,
which collectively enable early detection (via population screening), diagnoses, and monitoring response to
treatment. MRI of hyperpolarized noble gases (129Xe and 3He) reports on lung function: ventilation, diffusion,
and gas exchange. Despite remarkable research breakthroughs in this field demonstrating the effectiveness and
safety of hyperpolarized noble gas MRI to detect a wide range of lung diseases and monitor response to
treatment (over the past 20+ years of studies), the prospects for widespread clinical adaptation of this imaging
modality face major challenges, including (i) the high cost and complexity of the equipment for production of
hyperpolarized noble gases, and (ii) the requirement for a highly specialized custom MRI scanner capable of
129Xe or 3He imaging – note, all FDA-approved clinical MRI scanners can image only protons. We have been
developing a new technology of Parahydrogen Induced Polarization (PHIP) for production of pure proton-
hyperpolarized hydrocarbon gases via pairwise parahydrogen addition to an unsaturated precursor (e.g., vinyl
ether proposed here). This high-throughput technology is remarkably simple and low-cost. Most importantly, it
can be deployed on FDA-approved MRI scanners without any additional of hardware and software upgrades.
Here we propose applying this technology for production of diethyl ether, which has a rich history of use as the
first inhalable anesthetic, which has revolutionized the field of medicine. Specifically, we propose to develop and
optimize the process of clinical-scale production of a human dose of less than 100 mL of gas. Once inhaled, this
low dose diethyl ether will render in vivo concentration, which is no longer is flammable. Therefore, we envision
the use of low-dose proton-hyperpolarized diethyl ether as a safe MRI contrast agent. We will also perform
detailed mapping of relaxation properties of this novel HP contrast agents, and will perform feasibility imaging
studies in phantoms and excised animal lungs. We envision that this new safe inhalable contrast agent can
revolutionize pulmonary imaging and pulmonary medicine in general.
项目摘要(30行限制)
慢性阻塞性肺疾病(COPD)、哮喘、肺损伤、收缩性肺炎等致命疾病
细支气管炎和肺纤维化影响全世界> 3亿人,并且每年造成约300万人死亡。
然而,目前还没有广泛的临床成像模式来执行高分辨率功能肺
成像:计算机断层扫描(CT)、常规MRI和X射线只能提供致密的结构图像。
组织-提供肿瘤和肺炎等病理信息,但很少或根本没有关于肺的信息
通气、灌注、肺泡大小、气体交换效率等。这种状态与癌症形成对比
成像,包括MRI、CT、超声、乳房X线摄影、正电子发射断层扫描(PET)等,
这些措施共同实现了早期检测(通过人群筛查)、诊断和监测对
治疗超极化惰性气体(129 He和3 He)的MRI报告肺功能:通气,弥散,
气体交换。尽管在这一领域取得了显着的研究突破,
超极化惰性气体MRI检测各种肺部疾病并监测对
治疗(在过去20多年的研究),这种成像的广泛临床适应的前景
(i)生产的设备成本高,复杂性高,
超极化惰性气体,以及(ii)对高度专业化的定制MRI扫描仪的要求,
129氚或3 He成像-注意,所有FDA批准的临床MRI扫描仪只能成像质子。我们一直
开发了一种新的氢诱导极化(PHIP)技术,用于生产纯质子-
通过成对仲氢加成到不饱和前体的超极化烃气体(例如,乙烯基
在此提出)。这种高通量技术非常简单且成本低。最重要的是它
可以部署在FDA批准的MRI扫描仪上,无需任何额外的硬件和软件升级。
在这里,我们建议将这种技术应用于生产乙醚,乙醚作为
第一种吸入式麻醉剂,它彻底改变了医学领域。具体而言,我们建议发展和
优化临床规模生产人体剂量小于100 mL气体的工艺。一旦吸入,
低剂量乙醚将使体内浓度,这是不再易燃。因此,我们设想
使用低剂量质子超极化乙醚作为安全的MRI造影剂。我们还将表演
详细绘制这种新型HP造影剂的弛豫特性,并将进行可行性成像
在幻影和切除的动物肺中的研究。我们设想这种新的安全的可吸入造影剂可以
彻底改变了肺部成像和肺部医学。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bridging the Gap: From Homogeneous to Heterogeneous Parahydrogen-induced Hyperpolarization and Beyond.
- DOI:10.1002/cphc.202001031
- 发表时间:2021-04-19
- 期刊:
- 影响因子:0
- 作者:Chekmenev EY;Goodson BM;Bukhtiyarov VI;Koptyug IV
- 通讯作者:Koptyug IV
Background-Free Proton NMR Spectroscopy with Radiofrequency Amplification by Stimulated Emission Radiation.
- DOI:10.1002/anie.202108939
- 发表时间:2021-12-06
- 期刊:
- 影响因子:0
- 作者:Joalland B;Theis T;Appelt S;Chekmenev EY
- 通讯作者:Chekmenev EY
Clinical-Scale Production of Nearly Pure (>98.5%) Parahydrogen and Quantification by Benchtop NMR Spectroscopy.
- DOI:10.1021/acs.analchem.0c05129
- 发表时间:2021-02-23
- 期刊:
- 影响因子:7.4
- 作者:Nantogma S;Joalland B;Wilkens K;Chekmenev EY
- 通讯作者:Chekmenev EY
Low-Cost High-Pressure Clinical-Scale 50% Parahydrogen Generator Using Liquid Nitrogen at 77 K.
- DOI:10.1021/acs.analchem.1c00716
- 发表时间:2021-06-22
- 期刊:
- 影响因子:7.4
- 作者:Chapman B;Joalland B;Meersman C;Ettedgui J;Swenson RE;Krishna MC;Nikolaou P;Kovtunov KV;Salnikov OG;Koptyug IV;Gemeinhardt ME;Goodson BM;Shchepin RV;Chekmenev EY
- 通讯作者:Chekmenev EY
Heterogeneous Parahydrogen-Induced Polarization of Diethyl Ether for Magnetic Resonance Imaging Applications.
用于磁共振成像应用的非均相仲氢诱导乙醚极化。
- DOI:10.1002/chem.202003638
- 发表时间:2021-01-18
- 期刊:
- 影响因子:0
- 作者:Salnikov OG;Svyatova A;Kovtunova LM;Chukanov NV;Bukhtiyarov VI;Kovtunov KV;Chekmenev EY;Koptyug IV
- 通讯作者:Koptyug IV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eduard Chekmenev其他文献
Eduard Chekmenev的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eduard Chekmenev', 18)}}的其他基金
Rapid low-cost production of contrast agents for metabolic imaging
快速低成本生产代谢成像造影剂
- 批准号:
10572052 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Hyperpolarized Diethyl Ether for Sub-second Pulmonary MRI
用于亚秒级肺部 MRI 的超极化乙醚
- 批准号:
10040772 - 财政年份:2020
- 资助金额:
$ 22.86万 - 项目类别:
Magnetic Resonance Spectroscopy and Molecular Imaging of Metabolic Pathways in Cancer
癌症代谢途径的磁共振波谱和分子成像
- 批准号:
9381725 - 财政年份:2017
- 资助金额:
$ 22.86万 - 项目类别:
Magnetic Resonance Spectroscopy and Molecular Imaging of Metabolic Pathways in Cancer
癌症代谢途径的磁共振波谱和分子成像
- 批准号:
9755386 - 财政年份:2017
- 资助金额:
$ 22.86万 - 项目类别:
Pure parahydrogen-enhanced metabolic MRI contrast agents for molecular imaging
用于分子成像的纯仲氢增强代谢 MRI 造影剂
- 批准号:
9130178 - 财政年份:2015
- 资助金额:
$ 22.86万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
7941341 - 财政年份:2009
- 资助金额:
$ 22.86万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
7922512 - 财政年份:2008
- 资助金额:
$ 22.86万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
7914685 - 财政年份:2008
- 资助金额:
$ 22.86万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
7510655 - 财政年份:2008
- 资助金额:
$ 22.86万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
8088064 - 财政年份:2008
- 资助金额:
$ 22.86万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Studentship